M&G Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $671K | Buy |
8,826
+863
| +11% | +$65.6K | ﹤0.01% | 328 |
|
|
2023
Q3 | $549K | Buy |
7,963
+19
| +0.2% | +$1.31K | ﹤0.01% | 328 |
|
|
2023
Q2 | $747K | Sell |
7,944
-1,197
| -13% | -$113K | ﹤0.01% | 327 |
|
|
2023
Q1 | $759K | Sell |
9,141
-37,025
| -80% | -$3.07M | ﹤0.01% | 317 |
|
|
2022
Q4 | $3.46M | Buy |
+46,166
| New | +$3.46M | 0.02% | 243 |
|
|
2022
Q1 | – | Sell |
-1,736
| Closed | -$226 | – | 479 |
|
|
2021
Q4 | $226 | Sell |
1,736
-434,355
| -100% | -$56.5K | ﹤0.01% | 450 |
|
|
2021
Q3 | $49.3K | Buy |
436,091
+102,943
| +31% | +$11.6K | 0.12% | 112 |
|
|
2021
Q2 | $34.6K | Buy |
333,148
+330,538
| +12,664% | +$34.4K | 0.09% | 141 |
|
|
2021
Q1 | $219 | Sell |
2,610
-228
| -8% | -$19 | ﹤0.01% | 434 |
|
|
2020
Q4 | $258 | Hold |
2,838
| – | – | ﹤0.01% | 405 |
|
|
2020
Q3 | $227K | Buy |
+2,838
| New | +$227K | ﹤0.01% | 421 |
|
|
2020
Q2 | – | Sell |
-17,568
| Closed | -$1.11M | – | 417 |
|
|
2020
Q1 | $1.11M | Hold |
17,568
| – | – | 0.01% | 279 |
|
|
2019
Q4 | $1.36M | Buy |
+17,568
| New | +$1.36M | 0.01% | 297 |
|